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Analysis of a potential new model for neurovascular coupling in retina and its relation to 
the retinal relaxing factor. 
 
Since the first observations that retinal blood flow is higher in flickering light than in constant 
light, it is believed that there is a coupling of metabolism and blood flow in the eye. 
Adaptation of local arterial smooth muscle tone to neuronal activity (neurovascular coupling) 
is extensively studied in brain. Much less is known about the neurovascular coupling in retinal 
circulation. In the cerebrovascular circulation astrocytes can relay signals from neurons to 
vascular cells and in this way function as intermediaries between neurons and cerebral blood 
vessels to adjust blood flow to neuronal activity. Potential astrocyte-derived vasoactive 
mediators of cerebrovascular responses include for instance epoxyeicosatrienoic acids, 
prostaglandins, potassium and CO. 
 
About one decade ago our research group discovered that retinal tissue continuously releases 
an as yet unidentified retinal relaxing factor (RRF)
 1
. This was established in experiments on 
isolated bovine retinal arteries mounted for isometric tension recording. When a piece of 
retinal tissue was brought in close contact with a precontracted bovine retinal artery, this 
elicited a very strong relaxation that disappeared after removal of the retinal tissue. It was also 
found that contractility of bovine retinal arteries with adherent retinal tissue was much weaker 
than that of retinal arteries without retinal tissue.  The fact that RRF-induced relaxation was 
much more pronounced in hypoxic conditions indicated that this factor may be involved in 
neurovascular coupling in the retina. This research was in part supported by FRO grants 
offered to Christophe Delaey and Koen Boussery. 
 
During our recent research on RRF we observed that electrical field stimulation (EFS) of 
isolated and precontracted bovine retinal artery does not affect tone. This is in line with the 
absence of autonomic regulation of retinal circulation. However, when a retinal artery is 
surrounded by adherent retinal tissue, EFS (train duration 20sec; frequency 8Hz; pulse 
duration 5msec; 80V) elicits a rapid and reversible vasorelaxation (about 30 %).  The aim of 
the present project is to characterize this vasorelaxing effect, which may lead to a better 
understanding of neurovascular coupling in retina. 
 
Experiments will be performed using isolated retinal arteries with adherent retinal tissue 
mounted for isometric tension measurements in an oxygenated (5 % CO2 in O2) Krebs-Ringer 
bicarbonate solution at 37°C (pH= 7.4). After precontraction of the preparations with PGF2α 
(30 µM) EFS will be applied by a Grass stimulator via two parallel platinum electrodes on 
each side of the retinal artery. 
 
In a first series of experiments the frequency dependency of EFS will be investigated. In 
addition the influence of EFS will be investigated on non-precontracted preparations. This can 
reveal potential vasocontractile mediators that may simultaneously be released during EFS 
and may play a confounding role as modulators of the relaxation effect seen during EFS on 
precontracted preparations. 
  
In a next series of experiments it will be investigated whether EFS-induced retinal relaxation 
depends on activation of neuronal activity using tetrodotoxin. In addition experiments will be 
done using ω-conotoxin MVIIC, which inhibits calcium entry through presynaptic voltage-
gated calcium channels (N-, P-  and Q-type). This entry is an essential step in neurotransmitter 
release.  
 
We will also investigate whether astrocytes are involved in the neurovascular coupling in 
retina, using L-2-alpha aminoadipic acid, a selective astrocyte toxin. Astrocytes are believed 
to be accurate sensors of neuronal activity. Astrocytes respond to the synaptic release of 
glutamate with oscillations in the intracellular calcium concentration. Glutamate-mediated 
[Ca
2+
]i elevations in astrocytes trigger the release of vasoactive compounds 
2
. Therefore we 
will also investigate the influence of glutamate receptor antagonists that inhibit neuronal 
activity dependent [Ca
2+
]i elevations in astrocytes, but not in neurons.  
 
 
 
In another series of experiments we will address the question what vasoactive molecule(s) 
(released from glial cells and/or neurons) is involved in the EFS-induced relaxing response. 
One possibility is that under EFS more of the continuously liberated RRF is released by 
retinal cells. As the RRF response is inhibited in the presence of 120 mM of K
+ 1
 we will 
investigate the influence of 120 mM of K
+
 on EFS-induced relaxations.  
 
However, besides RRF many other neurotransmitters and glial cell-derived molecules can be 
considered as potential mediators of EFS-induced relaxation. The potential release of 
acetylcholine from cholinergic neurons, one of the most widely studied neurotransmitters in 
the retina 
3
, will be assessed using atropine. To investigate the involvement of NO released 
from nitrergic neurons, NO-synthase inhibitor nitro-L-arginine will be used. Given that 
activation of astrocytes triggers the release of prostaglandins 
2, 4
 and epoxyeicoatrienoic acids 
5
, we will investigate the influence of cyclooxygenase (COX) inhibitor indomethacin and the 
cytochrome P450 epoxygenase inhibitor miconazole on the EFS-induced relaxing response. 
Extensive evidence suggest that CO is a glutamate-induced, diffusible messenger used by 
astrocytes to signal for arteriole dilation by activation of smooth muscle cell Ca
2+
-sensitive K
+ 
(KCa) channels 
6
. Therefore, we will investigate the involvement of CO, using a KCa channel 
blocker such as paxilline, which blocks CO-induced vasodilation. Another possibility is the 
release of K
+
 by astrocytic KCa channels into the perivascular space to activate smooth muscle 
cell inward rectifier K
+
 (Kir) channels and cause vasodilation 
7
. Therefore, we will investigate 
the influence of blocking KCa and Kir channels on the EFS-induced vasorelaxing reponse. 
 
It is hoped that the result of these experiments would gain a better insight into the link 
between retinal metabolism and blood flow. 
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